Mirxes Holding Company Limited (HKG:2629)
Hong Kong · Delayed Price · Currency is HKD 30.80
+0.25 (0.82%)
At close: Aug 1, 2025, 4:00 PM HKT
Mirxes Holding Company Company Description
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits.
It also researches, develops, and manufactures biotechnology, life, and medical science related products.
The company was founded in 2014 and is headquartered in Singapore.
Mirxes Holding Company Limited
| Country | Cayman Islands |
| Founded | 2014 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 352 |
| CEO | Lihan Zhou |
Contact Details
Address: 2 Tukang Innovation Grove Singapore, 618305 Singapore | |
| Phone | 65 6816 2931 |
| Website | mirxes.com |
Stock Details
| Ticker Symbol | 2629 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Lihan Zhou | Chief Executive Officer |
| Beng Lor Choo | Chief Financial Officer |